BioCentury
ARTICLE | Financial News

BiondVax completes private placement

January 5, 2017 10:01 PM UTC

BiondVax raised NIS10.9 million ($2.8 million) through the sale of 33.8 million shares at NIS0.32 in a private placement with Angels High Tech Investments....

BCIQ Company Profiles

Scinai Immunotherapeutics Ltd.